Advances in antioxidant therapies for epidermolysis bullosa management
Year: 2025
Type: article
Abstract: Epidermolysis Bullosa (EB) is a rare genetic disorder characterized by skin and mucous membrane fragility. Oxidative stress is recognized as a major factor contributing to persistent and recurrent lesions. It can induce genomic damage, protein oxidation, lipid peroxidation, pathological angiogenesis and hypoxia. Despite the severity of the condition, therapeutic options remain limited. Here we explore the potential role of antioxidant compounds in EB patients, incorporating these compounds as a novel cornerstone in EB management.
Source: SKINdeep
Authors: Antonella Muñoz, Evelyng Catalán, Maria-Laura Cossio, Francis Palisson, Ignacia Fuentes
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W6962479872
FWCI:
Cites:
Cited by:
Related to:
